Comparative Pharmacokinetics of HD203, a Biosimilar of Etanercept, with Marketed Etanercept (Enbrel®)

The Pharmacokinetics of Etanercept in Healthy Volunteers

Joan Korth‐Bradley, Abbe Rubin, Roberta Hanna et al. · Annals of Pharmacotherapy · 2000 · 155 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Influence of height, weight and obesity on risk of breast cancer in an unselected Swedish population

Hans‐Olov Adami, Å Rimsten, Björn Stenkvist et al. · British Journal of Cancer · 1977 · 84 citations

Medicine, Oncology, Breast Oncology +10

Pharmacokinetic and Pharmacodynamic Profile of New Biosimilar Filgrastim XM02 Equivalent to Marketed Filgrastim Neupogen®

Heinz Lubenau, Peter Bias, Anne-Katrin Maly et al. · BioDrugs · 2009 · 60 citations

Medicine, Pharmacokinetics, Pharmacology +10

Biosimilars: a regulatory perspective from America

Jonathan Kay · Arthritis Research & Therapy · 2011 · 57 citations · Full text

Pharmacy, Biotechnology, Pharmaceutical Policy +17

Absence of a Pharmacokinetic Interaction between Etanercept and Warfarin

Honghui Zhou, Alain Patat, Virginia Parks et al. · The Journal of Clinical Pharmacology · 2004 · 40 citations

Medicine, Pharmacokinetics, Pharmacology +13